Acute heart failure following platinum and taxane-based chemotherapy for high grade ovarian cancer

Acute heart failure following platinum and taxane-based chemotherapy for high grade ovarian cancer

Detaylı Bibliyografya
Asıl Yazarlar:	Danielle S. Lewis, Jerry John, Shannon D. Armbruster
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	Elsevier 2025-02-01
Seri Bilgileri:	Gynecologic Oncology Reports
Online Erişim:	http://www.sciencedirect.com/science/article/pii/S2352578925000141

Benzer Materyaller

A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant Chemotherapy
Yazar:: Yixin Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2019-10-01)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
Yazar:: Alex Molassiotis, ve diğerleri
Baskı/Yayın Bilgisi: (2019-06-01)

Patients with Advanced Ovarian Cancer Administered Oral Etoposide following Taxane as Maintenance Chemotherapy
Yazar:: Hiroaki Nagano, ve diğerleri
Baskı/Yayın Bilgisi: (2016-03-01)

Palliative chemotherapy in carcinoma penis: Does platinum and taxane combination holds a promise?
Yazar:: Vijay M Patil, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers
Yazar:: Tibor A. Zwimpfer, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Platinum drugs and taxanes: can we overcome resistance?
Yazar:: Elena V. Sazonova, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study
Yazar:: Markowska Janina, ve diğerleri
Baskı/Yayın Bilgisi: (2008-01-01)

Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
Yazar:: Felisiak-Golabek Anna, ve diğerleri
Baskı/Yayın Bilgisi: (2011-11-01)

Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced NSCLC.
Yazar:: Seth A Brodie, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Maintenance chemotherapy after 6 cycles of platinum-doublet regimen in anthracycline-and taxane-pretreated metastatic breast cancer
Yazar:: Eun Kyo Joung, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

The effects and mechanism of taxanes on chemotherapy-associated ovarian damage: A review of current evidence
Yazar:: Chuqing Wu, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
Yazar:: Shirin Kianersi, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Taxanes and platinum derivatives impair Schwann cells via distinct mechanisms
Yazar:: Satoshi Imai, ve diğerleri
Baskı/Yayın Bilgisi: (2017-07-01)

Sequential Treatment of Advanced Squamous Lung Cancer:  First-line Gemcitabine +/- platinum Followed by Second-line Taxanes +/- platinum Versus Reverse Sequence
Yazar:: Jing XU, ve diğerleri
Baskı/Yayın Bilgisi: (2015-05-01)

Cell death in cancer chemotherapy using taxanes
Yazar:: Ana P. Xu, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Beau’s Lines Resulting from Taxane Chemotherapy
Yazar:: Kumpol Aiempanakit
Baskı/Yayın Bilgisi: (2018-10-01)

Genome-wide study of response to platinum, taxane, and combination therapy in ovarian cancer: in vitro phenotypes, inherited variation, and disease recurrence
Yazar:: Brooke L Fridley, ve diğerleri
Baskı/Yayın Bilgisi: (2016-03-01)

Circulating serum miRNAs predict response to platinum chemotherapy in high‐grade serous ovarian cancer
Yazar:: Kazuhiro Suzuki, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
Yazar:: Kaname Uno, ve diğerleri
Baskı/Yayın Bilgisi: (2022-03-01)

Combination chemotherapy with taxane and platinum in patients with salivary gland carcinoma: a retrospective study of docetaxel plus cisplatin and paclitaxel plus carboplatin
Yazar:: Ryutaro Onaga, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma
Yazar:: Irina Larionova, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer
Yazar:: Lan G. Coffman, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Taxane-induced acute interstitial pneumonitis in patients with breast cancer and outcome of taxane rechallenge
Yazar:: T M Anoop, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

RFWD3 modulates response to platinum chemotherapy and promotes cancer associated phenotypes in high grade serous ovarian cancer
Yazar:: Sarah J. Taylor, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

3468 Predictive biomarkers of platinum-based chemotherapy response in Puerto Rican Hispanics with high-grade serous ovarian cancer.
Yazar:: Jeyshka M. Reyes-Gonzalez, ve diğerleri
Baskı/Yayın Bilgisi: (2019-03-01)

Ovarian Carcinosarcoma: Effects of Cytoreductive Status and Platinum-Based Chemotherapy on Survival
Yazar:: Amelia M. Jernigan, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma
Yazar:: Zheng Feng, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Development and Validation of an Immune-Related Gene-Pair Model of High-Grade Serous Ovarian Cancer After Platinum-Based Chemotherapy
Yazar:: Jiaxing Lin, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Child outcomes after prenatal exposure to platinum and taxane-based chemotherapy: an unplanned interim analysis of the international network on cancer, infertility, and pregnancy studyResearch in context
Yazar:: Indra A. Van Assche, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

The Future of Chemotherapy: The Mechanisms and Benefits of Exercise in Taxane-Induced Peripheral Neuropathy
Yazar:: Sumedha Shastry, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Chemotherapy Associated Ovarian Failure
Yazar:: Davide Mauri, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Establishment and Genetic Profiling of Platinum/Taxane Doublet-Resistant Cells Generated by Hybridizing Single Resistant Cells
Yazar:: Seiji Isonishi, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Measurement properties of brief neuropathy screening items in cancer patients receiving taxanes, platinums, or proteasome inhibitors
Yazar:: Robert Knoerl, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Survival Analysis of Ovarian Carcinosarcomas Depending on Platinum or Doxorubicin Based Adjuvant Chemotherapy
Yazar:: İlker Selçuk, ve diğerleri
Baskı/Yayın Bilgisi: (2015-04-01)

Comprehensive analysis for the immune related biomarkers of platinum-based chemotherapy in ovarian cancer
Yazar:: Jiao Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
Yazar:: Carlos J Diaz Osterman, ve diğerleri
Baskı/Yayın Bilgisi: (2019-09-01)

Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy
Yazar:: Chuan-Jen Hung, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

A single-nucleotide polymorphism of the beta 2-adrenergic receptor gene can predict pathological complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer
Yazar:: Du Y, ve diğerleri
Baskı/Yayın Bilgisi: (2018-11-01)

Comparison of Efficacy and Safety of Taxanes Plus Platinum and Fluorouracil Plus Platinum in the First-Line Treatment of Esophageal Cancer: A Systematic Review and Meta-Analysis
Yazar:: Yue Zhao, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Taxane chemotherapy induces stromal injury that leads to breast cancer dormancy escape.
Yazar:: Ramya Ganesan, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)